Financial Metrics

HOLX HOLOGIC INC

Range: 2016-01-01 to 2026-04-29

Export Quarterly CSV Export Annual CSV

Chart Range:

% Change:

Annual View:

Financial Statements

Grouped by statement

Income Statement

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-26	0.24	—	USD/shares	10-Q	2017-05-10
Quarterly	2016-06-25	0.3	+25.0%	USD/shares	10-Q	2017-08-02
Quarterly	2016-12-31	0.3	+0.0%	USD/shares	10-Q	2018-02-08
Quarterly	2017-04-01	1.84	+513.3%	USD/shares	10-Q	2018-05-02
Quarterly	2017-07-01	0.21	-88.6%	USD/shares	10-Q	2018-07-31
Quarterly	2017-12-30	1.45	+590.5%	USD/shares	10-Q	2019-01-30
Quarterly	2018-03-31	-2.46	-269.7%	USD/shares	10-Q	2019-05-01
Quarterly	2018-06-30	0.41	+116.7%	USD/shares	10-Q	2019-07-31
Quarterly	2018-12-29	0.36	-12.2%	USD/shares	10-Q	2020-01-29
Quarterly	2019-03-30	-1.01	-380.6%	USD/shares	10-Q	2020-04-29
Quarterly	2019-06-29	0.35	+134.7%	USD/shares	10-Q	2020-07-29
Quarterly	2019-12-28	1.43	+308.6%	USD/shares	10-Q	2021-01-27
Quarterly	2020-03-28	0.36	-74.8%	USD/shares	10-Q	2021-04-28
Quarterly	2020-06-27	0.53	+47.2%	USD/shares	10-Q	2021-07-28
Quarterly	2020-12-26	2.5	+371.7%	USD/shares	10-Q	2022-02-02
Quarterly	2021-03-27	2.38	-4.8%	USD/shares	10-Q	2022-04-27
Quarterly	2021-06-26	1.04	-56.3%	USD/shares	10-Q	2022-07-27
Quarterly	2021-12-25	1.95	+87.5%	USD/shares	10-Q	2023-02-01
Quarterly	2022-03-26	1.8	-7.7%	USD/shares	10-Q	2023-05-02
Quarterly	2022-06-25	0.9	-50.0%	USD/shares	10-Q	2023-08-01
Quarterly	2022-12-31	0.75	-16.7%	USD/shares	10-Q	2024-02-02
Quarterly	2023-04-01	0.87	+16.0%	USD/shares	10-Q	2024-05-03
Quarterly	2023-07-01	-0.16	-118.4%	USD/shares	10-Q	2024-07-30
Quarterly	2023-12-30	1.03	+743.7%	USD/shares	10-Q	2025-02-06
Quarterly	2024-03-30	0.72	-30.1%	USD/shares	10-Q	2025-05-02
Quarterly	2024-06-29	0.82	+13.9%	USD/shares	10-Q	2025-07-31
Quarterly	2024-12-28	0.87	+6.1%	USD/shares	10-Q	2026-01-29
Quarterly	2025-03-29	-0.08	-109.2%	USD/shares	10-Q	2025-05-02
Quarterly	2025-06-28	0.86	+1175.0%	USD/shares	10-Q	2025-07-31
Quarterly	2025-12-27	0.79	-8.1%	USD/shares	10-Q	2026-01-29
Annual	2016-12-31	0.3	—	USD/shares	10-K	2018-11-20
Annual	2017-12-30	1.45	+383.3%	USD/shares	10-K	2019-11-27
Annual	2018-12-29	0.36	-75.2%	USD/shares	10-K	2020-11-17
Annual	2019-12-28	1.43	+297.2%	USD/shares	10-K	2020-11-17
Annual	2020-09-26	4.21	+194.4%	USD/shares	10-K	2022-11-15
Annual	2021-09-25	7.21	+71.3%	USD/shares	10-K	2023-11-21
Annual	2022-09-24	5.13	-28.8%	USD/shares	10-K	2024-11-27
Annual	2023-09-30	1.83	-64.3%	USD/shares	10-K	2025-11-18
Annual	2024-09-28	3.32	+81.4%	USD/shares	10-K	2025-11-18
Annual	2025-09-27	2.49	-25.0%	USD/shares	10-K	2025-11-18

Balance Sheet

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-26	3405700000.0	—	USD	10-Q	2016-04-27
Quarterly	2016-06-25	3422200000.0	+0.5%	USD	10-Q	2016-07-27
Quarterly	2016-09-24	3345400000.0	-2.2%	USD	10-Q	2017-08-02
Quarterly	2016-12-31	3322900000.0	-0.7%	USD	10-Q	2017-02-03
Quarterly	2017-04-01	3283200000.0	-1.2%	USD	10-Q	2017-05-10
Quarterly	2017-07-01	3220900000.0	-1.9%	USD	10-Q	2017-08-02
Quarterly	2017-09-30	3322900000.0	+3.2%	USD	10-Q	2018-07-31
Quarterly	2017-12-30	3329800000.0	+0.2%	USD	10-Q	2018-02-08
Quarterly	2018-03-31	3350700000.0	+0.6%	USD	10-Q	2018-05-02
Quarterly	2018-06-30	3247100000.0	-3.1%	USD	10-Q	2018-07-31
Quarterly	2018-09-29	3304300000.0	+1.8%	USD	10-Q	2019-07-31
Quarterly	2018-12-29	3127300000.0	-5.4%	USD	10-Q	2019-01-30
Quarterly	2019-03-30	3110400000.0	-0.5%	USD	10-Q	2019-05-01
Quarterly	2019-06-29	3053600000.0	-1.8%	USD	10-Q	2019-07-31
Quarterly	2019-09-28	3055000000.0	+0.0%	USD	10-Q	2020-07-29
Quarterly	2019-12-28	3071600000.0	+0.5%	USD	10-Q	2020-01-29
Quarterly	2020-03-28	3555400000.0	+15.8%	USD	10-Q	2020-04-29
Quarterly	2020-06-27	3296800000.0	-7.3%	USD	10-Q	2020-07-29
Quarterly	2020-09-26	3038800000.0	-7.8%	USD	10-Q	2021-07-28
Quarterly	2020-12-26	2764400000.0	-9.0%	USD	10-Q	2021-01-27
Quarterly	2021-03-27	2747000000.0	-0.6%	USD	10-Q	2021-04-28
Quarterly	2021-06-26	3115300000.0	+13.4%	USD	10-Q	2021-07-28
Quarterly	2021-09-25	3025200000.0	-2.9%	USD	10-Q	2022-07-27
Quarterly	2021-12-25	3068300000.0	+1.4%	USD	10-Q	2022-02-02
Quarterly	2022-03-26	3069600000.0	+0.0%	USD	10-Q	2022-04-27
Quarterly	2022-06-25	2822100000.0	-8.1%	USD	10-Q	2022-07-27
Quarterly	2022-09-24	2823400000.0	+0.0%	USD	10-Q	2023-08-01
Quarterly	2022-12-31	2826800000.0	+0.1%	USD	10-Q	2023-02-01
Quarterly	2023-04-01	2823900000.0	-0.1%	USD	10-Q	2023-05-02
Quarterly	2023-07-01	2821100000.0	-0.1%	USD	10-Q	2023-08-01
Quarterly	2023-09-30	2818200000.0	-0.1%	USD	10-Q	2024-07-30
Quarterly	2023-12-30	2560100000.0	-9.2%	USD	10-Q	2024-02-02
Quarterly	2024-03-30	2551500000.0	-0.3%	USD	10-Q	2024-05-03
Quarterly	2024-06-29	2543100000.0	-0.3%	USD	10-Q	2024-07-30
Quarterly	2024-09-28	2534600000.0	-0.3%	USD	10-Q	2025-07-31
Quarterly	2024-12-28	2526000000.0	-0.3%	USD	10-Q	2025-02-06
Quarterly	2025-03-29	2517500000.0	-0.3%	USD	10-Q	2025-05-02
Quarterly	2025-06-28	2509000000.0	-0.3%	USD	10-Q	2025-07-31
Quarterly	2025-09-27	2507900000.0	-0.0%	USD	10-Q	2026-01-29
Quarterly	2025-12-27	2508700000.0	+0.0%	USD	10-Q	2026-01-29
Annual	2016-09-24	3345400000.0	—	USD	10-K	2017-11-21
Annual	2017-09-30	3322900000.0	-0.7%	USD	10-K	2018-11-20
Annual	2018-09-29	3304300000.0	-0.6%	USD	10-K	2019-11-27
Annual	2019-09-28	3055000000.0	-7.5%	USD	10-K	2020-11-17
Annual	2020-09-26	3038800000.0	-0.5%	USD	10-K	2021-11-16
Annual	2021-09-25	3025200000.0	-0.4%	USD	10-K	2022-11-15
Annual	2022-09-24	2823400000.0	-6.7%	USD	10-K	2023-11-21
Annual	2023-09-30	2818200000.0	-0.2%	USD	10-K	2024-11-27
Annual	2024-09-28	2534600000.0	-10.1%	USD	10-K	2025-11-18
Annual	2025-09-27	2507900000.0	-1.1%	USD	10-K	2025-11-18

Cash Flow

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-26	19400000.0	—	USD	10-Q	2017-05-10
Quarterly	2016-06-25	27000000.0	+39.2%	USD	10-Q	2017-08-02
Quarterly	2016-12-31	11500000.0	-57.4%	USD	10-Q	2018-02-08
Quarterly	2017-04-01	24500000.0	+113.0%	USD	10-Q	2018-05-02
Quarterly	2017-07-01	35800000.0	+46.1%	USD	10-Q	2018-07-31
Quarterly	2017-12-30	10200000.0	-71.5%	USD	10-Q	2019-01-30
Quarterly	2018-03-31	24600000.0	+141.2%	USD	10-Q	2019-05-01
Quarterly	2018-06-30	37900000.0	+54.1%	USD	10-Q	2019-07-31
Quarterly	2018-12-29	9500000.0	-74.9%	USD	10-Q	2020-01-29
Quarterly	2019-03-30	23000000.0	+142.1%	USD	10-Q	2020-04-29
Quarterly	2019-06-29	37800000.0	+64.3%	USD	10-Q	2020-07-29
Quarterly	2019-12-28	11400000.0	-69.8%	USD	10-Q	2021-01-27
Quarterly	2020-03-28	29600000.0	+159.6%	USD	10-Q	2021-04-28
Quarterly	2020-06-27	53200000.0	+79.7%	USD	10-Q	2021-07-28
Quarterly	2020-12-26	32400000.0	-39.1%	USD	10-Q	2021-01-27
Quarterly	2021-03-27	51700000.0	+59.6%	USD	10-Q	2021-04-28
Quarterly	2021-06-26	71200000.0	+37.7%	USD	10-Q	2021-07-28
Quarterly	2023-07-01	55500000.0	-22.1%	USD	10-Q	2024-07-30
Quarterly	2023-12-30	22700000.0	-59.1%	USD	10-Q	2025-02-06
Quarterly	2024-03-30	35500000.0	+56.4%	USD	10-Q	2025-05-02
Quarterly	2024-06-29	56000000.0	+57.7%	USD	10-Q	2025-07-31
Quarterly	2024-12-28	16800000.0	-70.0%	USD	10-Q	2026-01-29
Quarterly	2025-03-29	32300000.0	+92.3%	USD	10-Q	2025-05-02
Quarterly	2025-06-28	45100000.0	+39.6%	USD	10-Q	2025-07-31
Quarterly	2025-12-27	14700000.0	-67.4%	USD	10-Q	2026-01-29
Annual	2016-09-24	47300000.0	—	USD	10-K	2018-11-20
Annual	2017-09-30	57800000.0	+22.2%	USD	10-K	2019-11-27
Annual	2018-09-29	58400000.0	+1.0%	USD	10-K	2020-11-17
Annual	2019-09-28	57000000.0	-2.4%	USD	10-K	2021-11-16
Annual	2020-09-26	98300000.0	+72.5%	USD	10-K	2022-11-15
Annual	2021-09-25	118300000.0	+20.3%	USD	10-K	2023-11-21
Annual	2022-09-24	70600000.0	-40.3%	USD	10-K	2024-11-27
Annual	2023-09-30	91800000.0	+30.0%	USD	10-K	2025-11-18
Annual	2024-09-28	72400000.0	-21.1%	USD	10-K	2025-11-18
Annual	2025-09-27	58800000.0	-18.8%	USD	10-K	2025-11-18

Share Data

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-26	287857000.0	—	shares	10-Q	2017-05-10
Quarterly	2016-06-25	282302000.0	-1.9%	shares	10-Q	2017-08-02
Quarterly	2016-12-31	284224000.0	+0.7%	shares	10-Q	2018-02-08
Quarterly	2017-04-01	286010000.0	+0.6%	shares	10-Q	2018-05-02
Quarterly	2017-07-01	287638000.0	+0.6%	shares	10-Q	2018-07-31
Quarterly	2017-12-30	280802000.0	-2.4%	shares	10-Q	2019-01-30
Quarterly	2018-03-31	277114000.0	-1.3%	shares	10-Q	2019-05-01
Quarterly	2018-06-30	275569000.0	-0.6%	shares	10-Q	2019-07-31
Quarterly	2018-12-29	272372000.0	-1.2%	shares	10-Q	2020-01-29
Quarterly	2019-03-30	269235000.0	-1.2%	shares	10-Q	2020-04-29
Quarterly	2019-06-29	270789000.0	+0.6%	shares	10-Q	2020-07-29
Quarterly	2019-12-28	269721000.0	-0.4%	shares	10-Q	2021-01-27
Quarterly	2020-03-28	264506000.0	-1.9%	shares	10-Q	2021-04-28
Quarterly	2020-06-27	261047000.0	-1.3%	shares	10-Q	2021-07-28
Quarterly	2020-12-26	261785000.0	+0.3%	shares	10-Q	2022-02-02
Quarterly	2021-03-27	260749000.0	-0.4%	shares	10-Q	2022-04-27
Quarterly	2021-06-26	258581000.0	-0.8%	shares	10-Q	2022-07-27
Quarterly	2021-12-25	256070000.0	-1.0%	shares	10-Q	2023-02-01
Quarterly	2022-03-26	253658000.0	-0.9%	shares	10-Q	2023-05-02
Quarterly	2022-06-25	253093000.0	-0.2%	shares	10-Q	2023-08-01
Quarterly	2022-12-31	249281000.0	-1.5%	shares	10-Q	2024-02-02
Quarterly	2023-04-01	249793000.0	+0.2%	shares	10-Q	2024-05-03
Quarterly	2023-07-01	246908000.0	-1.2%	shares	10-Q	2024-07-30
Quarterly	2023-12-30	240214000.0	-2.7%	shares	10-Q	2025-02-06
Quarterly	2024-03-30	237562000.0	-1.1%	shares	10-Q	2025-05-02
Quarterly	2024-06-29	236466000.0	-0.5%	shares	10-Q	2025-07-31
Quarterly	2024-12-28	232107000.0	-1.8%	shares	10-Q	2026-01-29
Quarterly	2025-03-29	225774000.0	-2.7%	shares	10-Q	2025-05-02
Quarterly	2025-06-28	225462000.0	-0.1%	shares	10-Q	2025-07-31
Quarterly	2025-12-27	225879000.0	+0.2%	shares	10-Q	2026-01-29
Annual	2016-09-24	286156000.0	—	shares	10-K	2018-11-20
Annual	2017-09-30	285653000.0	-0.2%	shares	10-K	2019-11-27
Annual	2018-09-29	275105000.0	-3.7%	shares	10-K	2020-11-17
Annual	2019-09-28	269413000.0	-2.1%	shares	10-K	2021-11-16
Annual	2020-09-26	264613000.0	-1.8%	shares	10-K	2022-11-15
Annual	2021-09-25	259706000.0	-1.9%	shares	10-K	2023-11-21
Annual	2022-09-24	253845000.0	-2.3%	shares	10-K	2024-11-27
Annual	2023-09-30	248831000.0	-2.0%	shares	10-K	2025-11-18
Annual	2024-09-28	237553000.0	-4.5%	shares	10-K	2025-11-18
Annual	2025-09-27	227573000.0	-4.2%	shares	10-K	2025-11-18

Credit and Bond Coverage

Company-level

Long-Term Debt (latest annual)

2,507,900,000

Total Liabilities (latest annual)

N/A

Current Liabilities (latest annual)

977,200,000

Metrics

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-26	0.0337	—	ratio	10-Q	2017-05-10
Quarterly	2016-06-25	0.0415	+23.2%	ratio	10-Q	2017-08-02
Quarterly	2016-12-31	0.0388	-6.5%	ratio	10-Q	2018-02-08
Quarterly	2017-04-01	0.1883	+385.2%	ratio	10-Q	2018-05-02
Quarterly	2017-07-01	0.0208	-89.0%	ratio	10-Q	2018-07-31
Quarterly	2017-12-30	0.1273	+513.3%	ratio	10-Q	2019-07-31
Quarterly	2018-03-31	-0.2786	-318.8%	ratio	10-Q	2019-07-31
Quarterly	2018-06-30	0.0461	+116.5%	ratio	10-Q	2019-07-31
Quarterly	2018-09-29	0.0208	-54.9%	ratio	10-Q	2019-07-31
Quarterly	2018-12-29	0.0412	+98.1%	ratio	10-Q	2020-07-29
Quarterly	2019-03-30	-0.1262	-406.5%	ratio	10-Q	2020-07-29
Quarterly	2019-06-29	0.0424	+133.6%	ratio	10-Q	2020-07-29
Quarterly	2019-09-28	-0.0584	-237.8%	ratio	10-Q	2020-07-29
Quarterly	2019-12-28	0.1709	+392.7%	ratio	10-Q	2021-07-28
Quarterly	2020-03-28	0.0453	-73.5%	ratio	10-Q	2021-07-28
Quarterly	2020-06-27	0.0604	+33.2%	ratio	10-Q	2021-07-28
Quarterly	2020-09-26	0.1823	+201.8%	ratio	10-Q	2021-07-28
Quarterly	2020-12-26	0.1999	+9.7%	ratio	10-Q	2022-07-27
Quarterly	2021-03-27	0.1632	-18.3%	ratio	10-Q	2022-07-27
Quarterly	2021-06-26	0.0691	-57.6%	ratio	10-Q	2022-07-27
Quarterly	2021-09-25	0.0779	+12.7%	ratio	10-Q	2022-07-27
Quarterly	2021-12-25	0.1105	+41.7%	ratio	10-Q	2023-08-01
Quarterly	2022-03-26	0.0951	-13.9%	ratio	10-Q	2023-08-01
Quarterly	2022-06-25	0.0457	-51.9%	ratio	10-Q	2023-08-01
Quarterly	2022-09-24	0.0243	-46.7%	ratio	10-Q	2023-08-01
Quarterly	2022-12-31	0.0368	+51.2%	ratio	10-Q	2024-07-30
Quarterly	2023-04-01	0.0412	+12.0%	ratio	10-Q	2024-07-30
Quarterly	2023-07-01	-0.0078	-119.0%	ratio	10-Q	2024-07-30
Quarterly	2023-09-30	0.0181	+331.1%	ratio	10-Q	2024-07-30
Quarterly	2023-12-30	0.0530	+193.3%	ratio	10-Q	2025-07-31
Quarterly	2024-03-30	0.0351	-33.8%	ratio	10-Q	2025-07-31
Quarterly	2024-06-29	0.0393	+12.0%	ratio	10-Q	2025-07-31
Quarterly	2024-09-28	0.0348	-11.4%	ratio	10-Q	2025-07-31
Quarterly	2024-12-28	0.0421	+21.0%	ratio	10-Q	2026-01-29
Quarterly	2025-03-29	-0.0038	-108.9%	ratio	10-Q	2026-01-29
Quarterly	2025-06-28	0.0402	+1168.3%	ratio	10-Q	2026-01-29
Quarterly	2025-09-27	0.0371	-7.9%	ratio	10-Q	2026-01-29
Quarterly	2025-12-27	0.0341	-7.9%	ratio	10-Q	2026-01-29
Annual	2020-09-26	0.4102	—	ratio	10-K	2022-11-15
Annual	2021-09-25	0.4432	+8.0%	ratio	10-K	2023-11-21
Annual	2022-09-24	0.2670	-39.8%	ratio	10-K	2024-11-27
Annual	2023-09-30	0.0909	-66.0%	ratio	10-K	2025-11-18
Annual	2024-09-28	0.1539	+69.3%	ratio	10-K	2025-11-18
Annual	2025-09-27	0.1121	-27.2%	ratio	10-K	2025-11-18

8-K Material Event Details

57 filings · 123 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

581 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value X-axis date:

All Transactions

Date	Insider	Title	Type	Security	Shares	Price	Total Value	Post-Tx Shares
2026-04-07	Verstreken Jan	Group President, International	Other disposed transaction D · derivative	Performance Stock Units	31,409	—	—	0
2026-04-07	Verstreken Jan	Group President, International	Equity grant / award A · derivative	Performance Stock Units	31,409	—	—	31,409
2026-04-07	Verstreken Jan	Group President, International	Other disposed transaction D · derivative	Non-qualified Stock Option (Right to Buy)	18,698	—	$1,484,434	0
2026-04-07	Verstreken Jan	Group President, International	Other disposed transaction D · derivative	Non-qualified Stock Option (Right to Buy)	20,056	—	$1,442,829	0
2026-04-07	Verstreken Jan	Group President, International	Other disposed transaction D · derivative	Non-qualified Stock Option (Right to Buy)	19,327	—	$1,436,962	0
2026-04-07	Verstreken Jan	Group President, International	Other disposed transaction D · derivative	Non-qualified Stock Option (Right to Buy)	17,831	—	$1,268,319	0
2026-04-07	Verstreken Jan	Group President, International	Other disposed transaction D · derivative	Non-qualified Stock Option (Right to Buy)	12,509	—	$854,990	0
2026-04-07	Verstreken Jan	Group President, International	Other disposed transaction D · derivative	Non-qualified Stock Option (Right to Buy)	29,002	—	$1,652,244	0
2026-04-07	Verstreken Jan	Group President, International	Other disposed transaction D · derivative	Non-qualified Stock Option (Right to Buy)	15,387	—	$701,801	0
2026-04-07	Verstreken Jan	Group President, International	Other disposed transaction D · derivative	Non-qualified Stock Option (Right to Buy)	13,971	—	$572,392	0
2026-04-07	Verstreken Jan	Group President, International	Other disposed transaction D · derivative	Non-qualified Stock Option (Right to Buy)	12,490	—	$510,216	0
2026-04-07	Verstreken Jan	Group President, International	Other disposed transaction D · derivative	Non-qualified Stock Option (Right to Buy)	7,564	—	$308,989	0
2026-04-07	Verstreken Jan	Group President, International	Other disposed transaction D	Common Stock	134,039	—	—	0
2026-02-27	Liddy Anne M.	General Counsel	Other disposed transaction F	Common Stock	185	$75.36	$13,942	28,052
2026-02-26	Wendell Amy McBride	Dir	Equity grant / award A	Common Stock	3,190	—	—	25,784
2026-02-10	Horvath Mark W.	President, Breast & Skeletal	Other disposed transaction F	Common Stock	113	$75.15	$8,492	23,026
2026-01-30	De Walt Diana	SVP, Human Resources	Other disposed transaction F	Common Stock	4,416	$74.93	$330,891	7,603
2026-01-30	De Walt Diana	SVP, Human Resources	Other disposed transaction F	Common Stock	4,416	$74.93	$330,891	7,603
2025-12-12	Schnittker Brandon	President, GYN Surgical	Other disposed transaction F	Common Stock	90	$75.00	$6,750	17,512
2025-11-14	MACMILLAN STEPHEN P	Chairman, President and CEO	Other disposed transaction F	Common Stock	6,874	$74.15	$509,707	1,423,837
2025-11-11	MACMILLAN STEPHEN P	Chairman, President and CEO	Other disposed transaction F	Common Stock	6,679	$74.60	$498,253	1,430,711
2025-11-10	Horvath Mark W.	President, Breast & Skeletal	Equity grant / award A	Common Stock	13,458	—	—	23,139
2025-11-10	MACMILLAN STEPHEN P	Chairman, President and CEO	Equity grant / award A	Common Stock	169,582	—	—	1,437,390
2025-11-07	MACMILLAN STEPHEN P	Chairman, President and CEO	Other disposed transaction F	Common Stock	50,405	$74.10	$3,735,010	1,267,808
2025-11-04	MACMILLAN STEPHEN P	Chairman, President and CEO	Equity grant / award A	Common Stock	83,589	—	—	1,318,213
2025-10-20	Stamoulis Christiana	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	7,402	$0.00	$0	0
2025-10-20	Stamoulis Christiana	Dir	Open-market sell S	Common Stock	7,402	$73.07	$540,864	47,336
2025-10-20	Stamoulis Christiana	Dir	Exercise / conversion M	Common Stock	7,402	$36.04	$266,768	54,738
2025-09-22	MACMILLAN STEPHEN P	Chairman, President and CEO	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	138,358	$0.00	$0	0
2025-09-22	MACMILLAN STEPHEN P	Chairman, President and CEO	Open-market sell S	Common Stock	38,700	$67.32	$2,605,284	1,234,624
2025-09-22	MACMILLAN STEPHEN P	Chairman, President and CEO	Open-market sell S	Common Stock	77,418	$67.04	$5,190,103	1,273,324
2025-09-22	MACMILLAN STEPHEN P	Chairman, President and CEO	Open-market sell S	Common Stock	22,240	$66.13	$1,470,731	1,350,742
2025-09-22	MACMILLAN STEPHEN P	Chairman, President and CEO	Exercise / conversion M	Common Stock	138,358	$39.96	$5,528,786	1,372,982
2025-05-30	Schnittker Brandon	Div. President, GYN Surgical	Other disposed transaction F	Common Stock	69	$62.17	$4,290	6,094
2025-05-07	Madaus Martin D	Dir	Open-market buy P	Common Stock	5,445	$55.24	$300,760	5,445
2025-04-07	McMillan Wayde D.	Dir	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	5,171	$0.00	$0	5,171
2025-04-07	McMillan Wayde D.	Dir	Equity grant / award A	Common Stock	1,742	—	—	1,742
2025-02-26	Wendell Amy McBride	Dir	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	5,535	$0.00	$0	5,535
2025-02-26	Wendell Amy McBride	Dir	Equity grant / award A	Common Stock	1,864	—	—	22,594
2025-02-10	Horvath Mark W.	Div. Pres., Breast & Skeletal	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	2,844	$0.00	$0	2,844
2025-02-10	Horvath Mark W.	Div. Pres., Breast & Skeletal	Equity grant / award A	Common Stock	958	—	—	7,057
2024-12-13	Schnittker Brandon	Div. President, GYN Surgical	Other disposed transaction F	Common Stock	90	$73.65	$6,628	6,163
2024-12-09	Madaus Martin D	Dir	Equity grant / award A	Common Stock	342	—	—	342
2024-12-04	Mitchell Essex D	Chief Operating Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	8,915	$0.00	$0	2,972
2024-12-04	Mitchell Essex D	Chief Operating Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	7,505	$0.00	$0	0
2024-12-04	Mitchell Essex D	Chief Operating Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	4,526	$0.00	$0	0
2024-12-04	Mitchell Essex D	Chief Operating Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	1,956	$0.00	$0	0
2024-12-04	Mitchell Essex D	Chief Operating Officer	Open-market sell S	Common Stock	24,856	$76.34	$1,897,482	27,957
2024-12-04	Mitchell Essex D	Chief Operating Officer	Exercise / conversion M	Common Stock	8,915	$71.13	$634,124	52,813
2024-12-04	Mitchell Essex D	Chief Operating Officer	Exercise / conversion M	Common Stock	7,505	$68.35	$512,967	43,898
2024-12-04	Mitchell Essex D	Chief Operating Officer	Exercise / conversion M	Common Stock	4,526	$45.61	$206,431	36,393
2024-12-04	Mitchell Essex D	Chief Operating Officer	Exercise / conversion M	Common Stock	1,956	$40.97	$80,137	31,867
2024-11-14	MACMILLAN STEPHEN P	Chairman, President and CEO	Other disposed transaction F	Common Stock	6,860	$77.54	$531,924	1,234,278
2024-11-11	MACMILLAN STEPHEN P	Chairman, President and CEO	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	117,801	$0.00	$0	117,801
2024-11-11	MACMILLAN STEPHEN P	Chairman, President and CEO	Equity grant / award A	Common Stock	39,677	—	—	1,241,138
2024-11-08	MACMILLAN STEPHEN P	Chairman, President and CEO	Other disposed transaction F	Common Stock	68,447	$78.76	$5,390,886	1,201,461
2024-11-07	MACMILLAN STEPHEN P	Chairman, President and CEO	Other disposed transaction F	Common Stock	6,214	$79.29	$492,708	1,269,908
2024-11-05	MACMILLAN STEPHEN P	Chairman, President and CEO	Equity grant / award A	Common Stock	118,560	—	—	1,276,122
2024-08-29	Oberton Karleen Marie	Chief Financial Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	6,725	$0.00	$0	0
2024-08-29	Oberton Karleen Marie	Chief Financial Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	26,080	$0.00	$0	0
2024-08-29	Oberton Karleen Marie	Chief Financial Officer	Open-market sell S	Common Stock	52,679	$80.56	$4,243,662	84,042
2024-08-29	Oberton Karleen Marie	Chief Financial Officer	Exercise / conversion M	Common Stock	6,725	$40.85	$274,716	136,721
2024-08-29	Oberton Karleen Marie	Chief Financial Officer	Exercise / conversion M	Common Stock	26,080	$40.97	$1,068,498	129,996
2024-08-06	Schnittker Brandon	Div. President, GYN Surgical	Open-market sell S	Common Stock	476	$83.11	$39,559	3,735
2024-08-01	COHN BENJAMIN JORDAN	Principal Accounting Officer	Open-market sell S	Common Stock	5,093	$81.99	$417,570	10,476
2024-07-30	MACMILLAN STEPHEN P	Chairman, President and CEO	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	44,039	$0.00	$0	0
2024-07-30	MACMILLAN STEPHEN P	Chairman, President and CEO	Open-market sell S	Common Stock	20,228	$82.32	$1,665,169	1,157,562
2024-07-30	MACMILLAN STEPHEN P	Chairman, President and CEO	Open-market sell S	Common Stock	16,177	$81.44	$1,317,455	1,177,790
2024-07-30	MACMILLAN STEPHEN P	Chairman, President and CEO	Open-market sell S	Common Stock	7,634	$80.60	$615,300	1,193,967
2024-07-30	MACMILLAN STEPHEN P	Chairman, President and CEO	Exercise / conversion M	Common Stock	44,039	$26.21	$1,154,262	1,201,601
2024-07-17	MACMILLAN STEPHEN P	Chairman, President and CEO	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	3,672	$0.00	$0	44,039
2024-07-17	MACMILLAN STEPHEN P	Chairman, President and CEO	Open-market sell S	Common Stock	3,672	$80.13	$294,223	1,157,562
2024-07-17	MACMILLAN STEPHEN P	Chairman, President and CEO	Exercise / conversion M	Common Stock	3,672	$26.21	$96,243	1,161,234
2024-05-31	Schnittker Brandon	Div. President, GYN Surgical	Other disposed transaction F	Common Stock	67	$73.78	$4,943	4,211
2024-05-23	MACMILLAN STEPHEN P	Chairman, President and CEO	Equity grant / award G	Common Stock	57,875	$0.00	$0	1,157,213
2024-04-22	MACMILLAN STEPHEN P	Chairman, President and CEO	Equity grant / award G	Common Stock	12,000	$0.00	$0	1,215,088
2024-04-19	MACMILLAN STEPHEN P	Chairman, President and CEO	Equity grant / award G	Common Stock	12,000	$0.00	$0	1,227,088
2024-03-14	GARRETT SCOTT T	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	7,402	$0.00	$0	0
2024-03-14	GARRETT SCOTT T	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	9,039	$0.00	$0	0
2024-03-14	GARRETT SCOTT T	Dir	Open-market sell S	Common Stock	16,441	$75.50	$1,241,296	48,611
2024-03-14	GARRETT SCOTT T	Dir	Exercise / conversion M	Common Stock	7,402	$36.04	$266,768	65,052
2024-03-14	GARRETT SCOTT T	Dir	Exercise / conversion M	Common Stock	9,039	$26.74	$241,703	57,650
2024-03-08	Dockendorff Charles J	Dir	Open-market sell S	Common Stock	1,465	$76.21	$111,648	1,572
2024-03-07	Dockendorff Charles J	Dir	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	4,536	$0.00	$0	4,536
2024-03-07	Dockendorff Charles J	Dir	Equity grant / award A	Common Stock	1,572	—	—	3,037
2024-01-29	Oberton Karleen Marie	Chief Financial Officer	Open-market sell S	Common Stock	14,940	$75.00	$1,120,500	103,916
2024-01-02	Dockendorff Charles J	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	7,551	$0.00	$0	0
2024-01-02	Dockendorff Charles J	Dir	Open-market sell S	Common Stock	16,017	$72.00	$1,153,224	1,465
2024-01-02	Dockendorff Charles J	Dir	Exercise / conversion M	Common Stock	7,551	$38.44	$290,260	17,482
2023-12-13	Dunne Peter Paul	SVP, Human Resources	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	3,554	$0.00	$0	3,554
2023-12-13	Dunne Peter Paul	SVP, Human Resources	Equity grant / award A	Common Stock	1,231	—	—	10,643
2023-12-11	GARRETT SCOTT T	Dir	Open-market sell S	Common Stock	10,000	$68.71	$687,116	47,039
2023-11-29	MACMILLAN STEPHEN P	Chairman, President and CEO	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	47,711	$0.00	$0	47,711
2023-11-29	MACMILLAN STEPHEN P	Chairman, President and CEO	Open-market sell S	Common Stock	47,711	$70.41	$3,359,188	1,239,088
2023-11-29	MACMILLAN STEPHEN P	Chairman, President and CEO	Exercise / conversion M	Common Stock	47,711	$26.21	$1,250,505	1,286,799
2023-11-21	Mitchell Essex D	Div. President, GYN Surgical	Open-market sell S	Common Stock	7,500	$71.85	$538,890	12,827
2023-11-14	MACMILLAN STEPHEN P	Chairman, President and CEO	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	117,829	$0.00	$0	117,829
2023-11-14	MACMILLAN STEPHEN P	Chairman, President and CEO	Equity grant / award A	Common Stock	40,832	—	—	1,239,088
2023-11-09	MACMILLAN STEPHEN P	Chairman, President and CEO	Other disposed transaction F	Common Stock	65,811	$67.20	$4,422,499	1,198,256
2023-11-08	MACMILLAN STEPHEN P	Chairman, President and CEO	Other disposed transaction F	Common Stock	5,442	$68.27	$371,525	1,264,067
2023-11-07	Verstreken Jan	Group President, International	Other disposed transaction F	Common Stock	247	$68.37	$16,887	80,617
2023-11-07	Schneiders Jennifer M	President, Diag. Solutions	Other disposed transaction F	Common Stock	154	$68.37	$10,529	3,157
2023-11-06	Verstreken Jan	Group President, International	Equity grant / award A	Common Stock	2,438	—	—	80,864
2023-09-20	Mohtashami Nanaz	Dir	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	2,141	$0.00	$0	2,141
2023-09-20	Mohtashami Nanaz	Dir	Equity grant / award A	Common Stock	745	—	—	745
2023-08-30	MACMILLAN STEPHEN P	Chairman, President and CEO	Equity grant / award G	Common Stock	1,064,954	$0.00	$0	1,249,350
2023-06-30	Verstreken Jan	Group President, International	Other disposed transaction F	Common Stock	322	$80.97	$26,072	78,426
2023-06-15	GARRETT SCOTT T	Dir	Open-market sell S	Common Stock	10,000	$79.72	$797,240	57,039
2023-05-05	Mitchell Essex D	Div. President, GYN Surgical	Open-market sell S	Common Stock	2,390	$83.73	$200,115	7,212
2023-03-09	Wendell Amy McBride	Dir	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	4,210	$0.00	$0	4,210
2023-03-09	Wendell Amy McBride	Dir	Equity grant / award A	Common Stock	1,465	—	—	19,158
2023-03-01	Anderson Erik S	Div. Pres., Breast & Skeletal	Other disposed transaction F	Common Stock	381	$79.06	$30,122	10,311
2023-02-07	Dockendorff Charles J	Dir	Equity grant / award G	Common Stock	1,336	$0.00	$0	0
2023-01-02	Stewart Stacey D.	Dir	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	768	$0.00	$0	768
2023-01-02	Stewart Stacey D.	Dir	Equity grant / award A	Common Stock	267	—	—	267
2022-12-14	Hellmann Elisabeth A	SVP, Human Resources	Open-market sell S	Common Stock	1,649	$76.40	$125,984	8,545
2022-12-05	Griffin John M.	General Counsel	Equity grant / award G	Common Stock	2,989	$0.00	$0	165,955
2022-11-30	MACMILLAN STEPHEN P	Chairman, President and CEO	Open-market sell S	Common Stock	12,501	$76.02	$950,326	2,313,970
2022-11-30	MACMILLAN STEPHEN P	Chairman, President and CEO	Open-market sell S	Common Stock	20,999	$75.43	$1,584,039	2,326,471
2022-11-15	Thornal Kevin R	Group Pres, Global Diagnostics	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	12,490	$0.00	$0	0
2022-11-15	Thornal Kevin R	Group Pres, Global Diagnostics	Open-market sell S	Common Stock	12,490	$75.30	$940,509	62,368
2022-11-15	Thornal Kevin R	Group Pres, Global Diagnostics	Exercise / conversion M	Common Stock	12,490	$40.85	$510,216	74,858
2022-11-15	Thornal Kevin R	Group Pres, Global Diagnostics	Open-market sell S	Common Stock	6,628	$75.37	$499,552	62,368
2022-11-14	Griffin John M.	General Counsel	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	26,902	$0.00	$0	0
2022-11-14	Griffin John M.	General Counsel	Open-market sell S	Common Stock	3,268	$76.49	$249,979	168,944
2022-11-14	Griffin John M.	General Counsel	Open-market sell S	Common Stock	23,634	$76.07	$1,797,909	172,212
2022-11-14	Griffin John M.	General Counsel	Exercise / conversion M	Common Stock	26,902	$40.85	$1,098,947	195,846
2022-11-11	MACMILLAN STEPHEN P	Chairman, President and CEO	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	95,422	$0.00	$0	95,422
2022-11-11	MACMILLAN STEPHEN P	Chairman, President and CEO	Other disposed transaction F	Common Stock	96,355	$75.93	$7,316,235	2,347,470
2022-11-11	MACMILLAN STEPHEN P	Chairman, President and CEO	Open-market sell S	Common Stock	42,893	$75.94	$3,257,294	2,443,825
2022-11-11	MACMILLAN STEPHEN P	Chairman, President and CEO	Open-market sell S	Common Stock	52,529	$75.57	$3,969,564	2,486,718
2022-11-11	MACMILLAN STEPHEN P	Chairman, President and CEO	Exercise / conversion M	Common Stock	95,422	$26.21	$2,501,011	2,539,247
2022-11-11	MACMILLAN STEPHEN P	Chairman, President and CEO	Open-market sell S	Common Stock	43,000	$75.64	$3,252,520	2,443,825
2022-11-09	MACMILLAN STEPHEN P	Chairman, President and CEO	Other disposed transaction F	Common Stock	5,776	$72.11	$416,507	2,486,825
2022-11-08	Thornal Kevin R	Group Pres, Global Diagnostics	Other disposed transaction F	Common Stock	709	$73.71	$52,260	78,367
2022-11-07	Thornal Kevin R	Group Pres, Global Diagnostics	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	19,327	$0.00	$0	19,327
2022-11-07	Thornal Kevin R	Group Pres, Global Diagnostics	Equity grant / award A	Common Stock	6,724	—	—	79,076
2022-11-01	MACMILLAN STEPHEN P	Chairman, President and CEO	Equity grant / award A	Common Stock	103,447	—	—	2,459,666
2022-07-01	Verstreken Jan	Group President, International	Other disposed transaction F	Common Stock	359	$70.14	$25,180	63,832
2022-05-17	Verstreken Jan	Group President, International	Open-market sell S	Common Stock	6,500	$78.80	$512,168	64,191
2022-05-13	COHN BENJAMIN JORDAN	Principal Accounting Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	3,842	$0.00	$0	3,844
2022-05-13	COHN BENJAMIN JORDAN	Principal Accounting Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	3,210	$0.00	$0	0
2022-05-13	COHN BENJAMIN JORDAN	Principal Accounting Officer	Open-market sell S	Common Stock	3,842	$75.49	$290,033	13,532
2022-05-13	COHN BENJAMIN JORDAN	Principal Accounting Officer	Exercise / conversion M	Common Stock	3,842	$40.85	$156,946	17,374
2022-05-13	COHN BENJAMIN JORDAN	Principal Accounting Officer	Open-market sell S	Common Stock	3,210	$75.49	$242,333	13,532
2022-05-13	COHN BENJAMIN JORDAN	Principal Accounting Officer	Exercise / conversion M	Common Stock	3,210	$37.64	$120,824	16,742
2022-05-03	COHN BENJAMIN JORDAN	Principal Accounting Officer	Open-market sell S	Common Stock	2,178	$74.18	$161,564	13,532
2022-03-10	Wendell Amy McBride	Dir	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	5,293	$0.00	$0	5,293
2022-03-10	Wendell Amy McBride	Dir	Equity grant / award A	Common Stock	1,565	—	—	17,693
2022-02-24	Daugherty Sean S.	Group President, BSH & Surg.	Open-market sell S	Common Stock	2,179	$71.14	$155,016	49,091
2021-11-19	COHN BENJAMIN JORDAN	Principal Accounting Officer	Open-market sell S	Common Stock	2,570	$75.79	$194,791	15,604
2021-11-12	MACMILLAN STEPHEN P	Chairman, President and CEO	Other disposed transaction F	Common Stock	91,777	$73.54	$6,749,281	2,355,893
2021-11-12	Verstreken Jan	Group President, International	Other disposed transaction F	Common Stock	2,027	$73.54	$149,066	70,691
2021-11-11	MACMILLAN STEPHEN P	Chairman, President and CEO	Other disposed transaction F	Common Stock	7,345	$72.61	$533,320	2,447,670
2021-11-09	MACMILLAN STEPHEN P	Chairman, President and CEO	Other disposed transaction F	Common Stock	4,173	$71.26	$297,368	2,455,015
2021-11-08	MACMILLAN STEPHEN P	Chairman, President and CEO	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	118,877	$0.00	$0	118,877
2021-11-08	MACMILLAN STEPHEN P	Chairman, President and CEO	Equity grant / award A	Common Stock	35,146	—	—	2,459,188
2021-11-01	MACMILLAN STEPHEN P	Chairman, President and CEO	Equity grant / award A	Common Stock	240,732	—	—	2,424,042
2021-08-10	COHN BENJAMIN JORDAN	Principal Accounting Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	5,000	$0.00	$0	3,210
2021-08-10	COHN BENJAMIN JORDAN	Principal Accounting Officer	Open-market sell S	Common Stock	5,000	$77.48	$387,425	16,896
2021-08-10	COHN BENJAMIN JORDAN	Principal Accounting Officer	Exercise / conversion M	Common Stock	5,000	$37.64	$188,200	21,896
2021-08-09	Griffin John M.	General Counsel	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	26,683	$0.00	$0	0
2021-08-09	Griffin John M.	General Counsel	Open-market sell S	Common Stock	26,683	$75.62	$2,017,768	123,600
2021-08-09	Griffin John M.	General Counsel	Exercise / conversion M	Common Stock	26,683	$37.64	$1,004,348	150,283
2021-07-01	Verstreken Jan	Group President, International	Other disposed transaction F	Common Stock	351	$67.99	$23,864	44,669
2021-05-10	Daugherty Sean S.	Group President, BSH & Surg.	Open-market sell S	Common Stock	4,001	$65.02	$260,149	26,613
2021-03-11	Dockendorff Charles J	Dir	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	5,055	$0.00	$0	5,055
2021-03-11	Dockendorff Charles J	Dir	Equity grant / award A	Common Stock	1,478	—	—	3,695
2021-02-05	Bebo Allison P	SVP, Human Resources	Open-market sell S	Common Stock	6,100	$84.06	$512,778	35,680
2021-02-04	COHN BENJAMIN JORDAN	Principal Accounting Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	8,396	$0.00	$0	0
2021-02-04	COHN BENJAMIN JORDAN	Principal Accounting Officer	Open-market sell S	Common Stock	8,396	$84.31	$707,867	16,652
2021-02-04	COHN BENJAMIN JORDAN	Principal Accounting Officer	Exercise / conversion M	Common Stock	8,396	$39.96	$335,504	25,048
2020-12-10	Thornal Kevin R	Div. President, Diagnostics	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	9,236	$0.00	$0	0
2020-12-10	Thornal Kevin R	Div. President, Diagnostics	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	7,633	$0.00	$0	0
2020-12-10	Thornal Kevin R	Div. President, Diagnostics	Open-market sell S	Common Stock	9,236	$73.99	$683,409	33,216
2020-12-10	Thornal Kevin R	Div. President, Diagnostics	Exercise / conversion M	Common Stock	9,236	$37.64	$347,643	42,452
2020-12-10	Thornal Kevin R	Div. President, Diagnostics	Open-market sell S	Common Stock	7,633	$74.00	$564,804	33,216
2020-12-10	Thornal Kevin R	Div. President, Diagnostics	Exercise / conversion M	Common Stock	7,633	$39.96	$305,015	40,849
2020-12-01	MACMILLAN STEPHEN P	Chairman, President and CEO	Other disposed transaction F	Common Stock	439,919	$69.63	$30,631,560	2,203,217
2020-11-18	Griffin John M.	General Counsel	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	22,900	$0.00	$0	0
2020-11-18	Griffin John M.	General Counsel	Open-market sell S	Common Stock	11,579	$71.35	$826,208	134,486
2020-11-18	Griffin John M.	General Counsel	Open-market sell S	Common Stock	11,321	$70.80	$801,482	146,065
2020-11-18	Griffin John M.	General Counsel	Exercise / conversion M	Common Stock	22,900	$39.96	$915,084	157,386
2020-11-17	COHN BENJAMIN JORDAN	Principal Accounting Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	5,000	$0.00	$0	0
2020-11-17	COHN BENJAMIN JORDAN	Principal Accounting Officer	Open-market sell S	Common Stock	5,000	$72.58	$362,900	18,292
2020-11-17	COHN BENJAMIN JORDAN	Principal Accounting Officer	Exercise / conversion M	Common Stock	5,000	$26.21	$131,050	23,292
2020-11-12	MACMILLAN STEPHEN P	Chairman, President and CEO	Other disposed transaction F	Common Stock	8,179	$70.20	$574,166	2,643,136
2020-11-11	MACMILLAN STEPHEN P	Chairman, President and CEO	Other disposed transaction F	Common Stock	7,633	$69.84	$533,089	2,651,315
2020-11-09	MACMILLAN STEPHEN P	Chairman, President and CEO	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	123,801	$0.00	$0	123,801
2020-11-09	MACMILLAN STEPHEN P	Chairman, President and CEO	Equity grant / award A	Common Stock	36,199	—	—	2,658,948
2020-11-04	Stamoulis Christiana	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	11,146	$0.00	$0	0
2020-11-04	Stamoulis Christiana	Dir	Open-market sell S	Common Stock	11,146	$74.00	$824,804	39,392
2020-11-04	Stamoulis Christiana	Dir	Exercise / conversion M	Common Stock	11,146	$22.35	$249,113	50,538
2020-11-02	MACMILLAN STEPHEN P	Chairman, President and CEO	Equity grant / award A	Common Stock	900,307	—	—	2,622,749
2020-09-22	Oberton Karleen Marie	Chief Financial Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	5,461	$0.00	$0	0
2020-09-22	Oberton Karleen Marie	Chief Financial Officer	Exercise / conversion M	Common Stock	5,461	$26.21	$143,133	34,417
2020-09-21	Oberton Karleen Marie	Chief Financial Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	15,000	$0.00	$0	5,461
2020-09-21	Oberton Karleen Marie	Chief Financial Officer	Open-market sell S	Common Stock	15,000	$62.50	$937,500	28,956
2020-09-21	Oberton Karleen Marie	Chief Financial Officer	Exercise / conversion M	Common Stock	15,000	$26.21	$393,150	43,956
2020-08-03	COHN BENJAMIN JORDAN	Principal Accounting Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	2,986	$0.00	$0	0
2020-08-03	COHN BENJAMIN JORDAN	Principal Accounting Officer	Open-market sell S	Common Stock	2,617	$71.23	$186,409	16,713
2020-08-03	COHN BENJAMIN JORDAN	Principal Accounting Officer	Open-market sell S	Common Stock	369	$71.22	$26,280	19,330
2020-08-03	COHN BENJAMIN JORDAN	Principal Accounting Officer	Exercise / conversion M	Common Stock	2,986	$23.82	$71,127	19,699
2020-08-03	COHN BENJAMIN JORDAN	Principal Accounting Officer	Open-market sell S	Common Stock	1,938	$71.27	$138,121	16,713
2020-06-30	Valenti Peter J. III	Division Pres., Breast Health	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	10,493	$0.00	$0	0
2020-06-30	Valenti Peter J. III	Division Pres., Breast Health	Open-market sell S	Common Stock	10,493	$54.07	$567,357	59,991
2020-06-30	Valenti Peter J. III	Division Pres., Breast Health	Exercise / conversion M	Common Stock	10,493	$26.21	$275,022	70,484
2020-05-22	Valenti Peter J. III	Division Pres., Breast Health	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	10,493	$0.00	$0	10,493
2020-05-22	Valenti Peter J. III	Division Pres., Breast Health	Open-market sell S	Common Stock	10,493	$51.82	$543,779	59,991
2020-05-22	Valenti Peter J. III	Division Pres., Breast Health	Exercise / conversion M	Common Stock	10,493	$26.21	$275,022	70,484
2020-05-15	Thornal Kevin R	Div. President, Diagnostics	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	13,888	$0.00	$0	0
2020-05-15	Thornal Kevin R	Div. President, Diagnostics	Open-market sell S	Common Stock	13,888	$51.51	$715,426	17,026
2020-05-15	Thornal Kevin R	Div. President, Diagnostics	Exercise / conversion M	Common Stock	13,888	$26.01	$361,227	30,914
2020-05-13	MACMILLAN STEPHEN P	Chairman, President and CEO	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	215,996	$0.00	$0	0
2020-05-13	MACMILLAN STEPHEN P	Chairman, President and CEO	Open-market sell S	Common Stock	190,996	$50.97	$9,735,257	1,722,442
2020-05-13	MACMILLAN STEPHEN P	Chairman, President and CEO	Exercise / conversion M	Common Stock	215,996	$22.29	$4,814,551	1,913,438
2020-05-01	GARRETT SCOTT T	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	24,204	$0.00	$0	0
2020-05-01	GARRETT SCOTT T	Dir	Exercise / conversion M	Common Stock	24,204	$20.34	$492,309	51,385
2020-04-28	Griffin John M.	General Counsel	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	2,133	$0.00	$0	0
2020-04-28	Griffin John M.	General Counsel	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	2,773	$0.00	$0	0
2020-04-28	Griffin John M.	General Counsel	Open-market sell S	Common Stock	2,133	$50.00	$106,650	95,307
2020-04-28	Griffin John M.	General Counsel	Exercise / conversion M	Common Stock	2,133	$32.38	$69,067	97,440
2020-04-28	Griffin John M.	General Counsel	Open-market sell S	Common Stock	2,773	$50.00	$138,650	95,307
2020-04-28	Griffin John M.	General Counsel	Exercise / conversion M	Common Stock	2,773	$32.38	$89,790	98,080
2020-03-09	CRAWFORD SALLY	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	11,146	$0.00	$0	0
2020-03-09	CRAWFORD SALLY	Dir	Open-market sell S	Common Stock	7,846	$44.29	$347,523	158,797
2020-03-09	CRAWFORD SALLY	Dir	Open-market sell S	Common Stock	3,300	$43.57	$143,794	166,643
2020-03-09	CRAWFORD SALLY	Dir	Exercise / conversion M	Common Stock	11,146	$22.35	$249,113	169,943
2020-03-05	Wendell Amy McBride	Dir	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	7,322	$0.00	$0	7,322
2020-03-05	Wendell Amy McBride	Dir	Equity grant / award A	Common Stock	2,217	—	—	14,650
2020-02-03	MACMILLAN STEPHEN P	Chairman, President and CEO	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	215,996	$0.00	$0	215,996
2020-02-03	MACMILLAN STEPHEN P	Chairman, President and CEO	Open-market sell S	Common Stock	194,396	$53.54	$10,407,184	1,697,442
2020-02-03	MACMILLAN STEPHEN P	Chairman, President and CEO	Exercise / conversion M	Common Stock	215,996	$22.29	$4,814,551	1,891,838
2020-01-13	Griffin John M.	General Counsel	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	11,092	$0.00	$0	2,773
2020-01-13	Griffin John M.	General Counsel	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	8,532	$0.00	$0	2,133
2020-01-13	Griffin John M.	General Counsel	Open-market sell S	Common Stock	11,092	$52.78	$585,402	95,307
2020-01-13	Griffin John M.	General Counsel	Exercise / conversion M	Common Stock	11,092	$32.38	$359,159	106,399
2020-01-13	Griffin John M.	General Counsel	Open-market sell S	Common Stock	8,532	$52.97	$451,932	95,307
2020-01-13	Griffin John M.	General Counsel	Exercise / conversion M	Common Stock	8,532	$35.38	$301,862	103,839
2020-01-13	Griffin John M.	General Counsel	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	8,532	$0.00	$0	2,133
2020-01-13	Griffin John M.	General Counsel	Exercise / conversion M	Common Stock	8,532	$32.38	$276,266	103,839
2020-01-02	Oberton Karleen Marie	Chief Financial Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	5,973	$0.00	$0	0
2020-01-02	Oberton Karleen Marie	Chief Financial Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	10,375	$0.00	$0	0
2020-01-02	Oberton Karleen Marie	Chief Financial Officer	Open-market sell S	Common Stock	5,973	$51.85	$309,694	28,956
2020-01-02	Oberton Karleen Marie	Chief Financial Officer	Open-market sell S	Common Stock	10,375	$51.66	$535,993	34,929
2020-01-02	Oberton Karleen Marie	Chief Financial Officer	Exercise / conversion M	Common Stock	5,973	$23.82	$142,277	45,304
2020-01-02	Oberton Karleen Marie	Chief Financial Officer	Exercise / conversion M	Common Stock	10,375	$21.45	$222,544	39,331
2019-12-04	COHN BENJAMIN JORDAN	Principal Accounting Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	4,379	$0.00	$0	0
2019-12-04	COHN BENJAMIN JORDAN	Principal Accounting Officer	Open-market sell S	Common Stock	4,379	$52.12	$228,225	18,162
2019-12-04	COHN BENJAMIN JORDAN	Principal Accounting Officer	Exercise / conversion M	Common Stock	4,379	$21.45	$93,930	22,541
2019-12-03	MACMILLAN STEPHEN P	Chairman, President and CEO	Other disposed transaction J	Common Stock	13,716	$51.69	$708,980	1,675,842
2019-12-01	MACMILLAN STEPHEN P	Chairman, President and CEO	Other disposed transaction F	Common Stock	8,387	$51.32	$430,421	1,689,558
2019-12-01	MACMILLAN STEPHEN P	Chairman, President and CEO	Other disposed transaction F	Common Stock	4,772	$51.32	$244,899	1,697,945
2019-11-22	COHN BENJAMIN JORDAN	Principal Accounting Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	4,400	$0.00	$0	4,379
2019-11-22	COHN BENJAMIN JORDAN	Principal Accounting Officer	Open-market sell S	Common Stock	4,400	$50.09	$220,400	18,663
2019-11-22	COHN BENJAMIN JORDAN	Principal Accounting Officer	Exercise / conversion M	Common Stock	4,400	$21.45	$94,380	23,063
2019-11-12	MACMILLAN STEPHEN P	Chairman, President and CEO	Other disposed transaction F	Common Stock	8,178	$46.15	$377,415	1,702,717
2019-11-11	MACMILLAN STEPHEN P	Chairman, President and CEO	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	152,529	$0.00	$0	152,529
2019-11-11	MACMILLAN STEPHEN P	Chairman, President and CEO	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	21,600	$0.00	$0	431,992
2019-11-11	MACMILLAN STEPHEN P	Chairman, President and CEO	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	194,396	$0.00	$0	453,592
2019-11-11	MACMILLAN STEPHEN P	Chairman, President and CEO	Equity grant / award A	Common Stock	21,925	—	—	1,710,895
2019-11-11	MACMILLAN STEPHEN P	Chairman, President and CEO	Equity grant / award A	Common Stock	46,183	—	—	1,688,970
2019-11-11	MACMILLAN STEPHEN P	Chairman, President and CEO	Equity grant / award A	Common Stock	33,772	—	—	1,642,787
2019-11-11	MACMILLAN STEPHEN P	Chairman, President and CEO	Exercise / conversion M	Common Stock	21,600	$22.29	$481,464	1,609,015
2019-11-11	MACMILLAN STEPHEN P	Chairman, President and CEO	Open-market sell S	Common Stock	126,956	$46.16	$5,859,908	1,587,415
2019-11-11	MACMILLAN STEPHEN P	Chairman, President and CEO	Open-market sell S	Common Stock	67,440	$45.44	$3,064,743	1,714,371
2019-11-11	MACMILLAN STEPHEN P	Chairman, President and CEO	Exercise / conversion M	Common Stock	194,396	$22.29	$4,333,087	1,781,811
2019-09-03	Valenti Peter J. III	Division Pres., Breast Health	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	7,766	$0.00	$0	0
2019-09-03	Valenti Peter J. III	Division Pres., Breast Health	Open-market sell S	Common Stock	7,766	$49.14	$381,621	50,353
2019-09-03	Valenti Peter J. III	Division Pres., Breast Health	Exercise / conversion M	Common Stock	7,766	$23.82	$184,986	58,119
2019-08-05	MACMILLAN STEPHEN P	Chairman, President and CEO	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	215,996	$0.00	$0	647,988
2019-08-05	MACMILLAN STEPHEN P	Chairman, President and CEO	Open-market sell S	Common Stock	81,945	$49.26	$4,036,938	1,587,415
2019-08-05	MACMILLAN STEPHEN P	Chairman, President and CEO	Open-market sell S	Common Stock	112,451	$48.41	$5,444,090	1,669,360
2019-08-05	MACMILLAN STEPHEN P	Chairman, President and CEO	Exercise / conversion M	Common Stock	215,996	$22.29	$4,814,551	1,781,811
2019-06-03	Valenti Peter J. III	Division Pres., Breast Health	Open-market sell S	Common Stock	4,545	$44.07	$200,298	50,353
2019-03-18	CRAWFORD SALLY	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	12,306	$0.00	$0	0
2019-03-18	CRAWFORD SALLY	Dir	Open-market sell S	Common Stock	12,306	$47.61	$585,889	156,580
2019-03-18	CRAWFORD SALLY	Dir	Exercise / conversion M	Common Stock	12,306	$20.01	$246,243	168,886
2019-03-11	COHN BENJAMIN JORDAN	Principal Accounting Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	6,830	$0.00	$0	0
2019-03-11	COHN BENJAMIN JORDAN	Principal Accounting Officer	Open-market sell S	Common Stock	6,830	$46.70	$318,961	15,172
2019-03-11	COHN BENJAMIN JORDAN	Principal Accounting Officer	Exercise / conversion M	Common Stock	6,830	$19.86	$135,644	22,002
2019-03-07	Wendell Amy McBride	Dir	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	6,523	$0.00	$0	6,523
2019-03-07	Wendell Amy McBride	Dir	Equity grant / award A	Common Stock	2,136	—	—	12,433
2019-03-01	Valenti Peter J. III	Division Pres., Breast Health	Open-market sell S	Common Stock	4,242	$47.38	$200,986	54,898
2019-02-02	Bebo Allison P	SVP, Human Resources	Other disposed transaction F	Common Stock	589	$43.70	$25,739	23,019
2018-12-07	Valenti Peter J. III	Division Pres., Breast Health	Open-market sell S	Common Stock	4,740	$42.20	$200,028	59,140
2018-12-01	COHN BENJAMIN JORDAN	Principal Accounting Officer	Other disposed transaction F	Common Stock	241	$44.41	$10,703	14,993
2018-12-01	COHN BENJAMIN JORDAN	Principal Accounting Officer	Other disposed transaction F	Common Stock	261	$44.41	$11,591	15,234
2018-12-01	West Thomas A.	Div President & GM, Diagnostic	Other disposed transaction F	Common Stock	1,011	$44.41	$44,899	55,753
2018-11-30	COHN BENJAMIN JORDAN	Principal Accounting Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	10,000	$0.00	$0	6,830
2018-11-30	COHN BENJAMIN JORDAN	Principal Accounting Officer	Open-market sell S	Common Stock	10,000	$44.49	$444,870	15,495
2018-11-30	COHN BENJAMIN JORDAN	Principal Accounting Officer	Exercise / conversion M	Common Stock	10,000	$19.86	$198,600	25,495
2018-11-28	Stamoulis Christiana	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	13,257	$0.00	$0	0
2018-11-28	Stamoulis Christiana	Dir	Open-market sell S	Common Stock	13,257	$44.50	$589,950	35,039
2018-11-28	Stamoulis Christiana	Dir	Exercise / conversion M	Common Stock	13,257	$17.51	$232,130	48,296
2018-11-21	HANTSON LUDWIG	Dir	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	2,012	$0.00	$0	2,012
2018-11-21	HANTSON LUDWIG	Dir	Equity grant / award A	Common Stock	659	—	—	659
2018-11-16	Bebo Allison P	SVP, Human Resources	Open-market sell S	Common Stock	6,500	$42.00	$273,000	24,736
2018-11-12	West Thomas A.	Div President & GM, Diagnostic	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	20,491	$0.00	$0	20,491
2018-11-12	West Thomas A.	Div President & GM, Diagnostic	Equity grant / award A	Common Stock	6,712	—	—	56,764
2018-11-07	COHN BENJAMIN JORDAN	Principal Accounting Officer	Other disposed transaction F	Common Stock	309	$41.26	$12,749	12,506
2018-11-05	Valenti Peter J. III	Division Pres., Breast Health	Exercise / conversion M · derivative	Restricted Stock Unit Award (Right To Receive)	2,086	—	—	0
2018-11-05	Valenti Peter J. III	Division Pres., Breast Health	Equity grant / award A	Common Stock	14,388	—	—	55,570
2018-11-05	Valenti Peter J. III	Division Pres., Breast Health	Exercise / conversion M	Common Stock	2,086	—	—	41,182
2018-10-02	Stamoulis Christiana	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	30,967	$0.00	$0	0
2018-10-02	Stamoulis Christiana	Dir	Open-market sell S	Common Stock	30,967	$40.70	$1,260,481	35,039
2018-10-02	Stamoulis Christiana	Dir	Exercise / conversion M	Common Stock	30,967	$15.29	$473,485	66,006
2018-09-19	COHN BENJAMIN JORDAN	Principal Accounting Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	3,437	$0.00	$0	0
2018-09-19	COHN BENJAMIN JORDAN	Principal Accounting Officer	Open-market sell S	Common Stock	3,437	$41.50	$142,636	13,083
2018-09-19	COHN BENJAMIN JORDAN	Principal Accounting Officer	Exercise / conversion M	Common Stock	3,437	$17.09	$58,738	16,520
2018-09-17	CRAWFORD SALLY	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	13,257	$0.00	$0	0
2018-09-17	CRAWFORD SALLY	Dir	Open-market sell S	Common Stock	13,257	$39.54	$524,169	154,444
2018-09-17	CRAWFORD SALLY	Dir	Exercise / conversion M	Common Stock	13,257	$17.51	$232,130	167,701
2018-08-02	McMahon Robert W.	Chief Financial Officer	Other disposed transaction F	Common Stock	7,699	$42.12	$324,282	112,244
2018-05-29	Valenti Peter J. III	Division Pres., Breast Health	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	7,766	$0.00	$0	7,766
2018-05-29	Valenti Peter J. III	Division Pres., Breast Health	Open-market sell S	Common Stock	7,766	$38.52	$299,146	39,096
2018-05-29	Valenti Peter J. III	Division Pres., Breast Health	Exercise / conversion M	Common Stock	7,766	$23.82	$184,986	46,862
2018-05-29	Valenti Peter J. III	Division Pres., Breast Health	Open-market sell S	Common Stock	2,341	$38.52	$90,175	39,096
2018-05-26	McMahon Robert W.	Chief Financial Officer	Exercise / conversion M · derivative	Restricted Stock Unit Award (Right To Receive)	7,347	—	$0	0
2018-05-26	McMahon Robert W.	Chief Financial Officer	Exercise / conversion M	Common Stock	7,347	—	—	119,943
2018-05-25	Valenti Peter J. III	Division Pres., Breast Health	Exercise / conversion M · derivative	Restricted Stock Unit Award (Right To Receive)	3,411	—	—	0
2018-05-25	Valenti Peter J. III	Division Pres., Breast Health	Other disposed transaction F	Common Stock	1,070	$38.92	$41,644	41,437
2018-05-25	Valenti Peter J. III	Division Pres., Breast Health	Exercise / conversion M	Common Stock	3,411	—	—	42,507
2018-05-02	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	7,994	$0.00	$0	0
2018-05-02	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	4,202	$0.00	$0	0
2018-05-02	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Open-market sell S	Common Stock	7,994	$40.00	$319,760	9,623
2018-05-02	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Exercise / conversion M	Common Stock	7,994	$19.86	$158,761	17,617
2018-05-02	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Open-market sell S	Common Stock	4,202	$40.00	$168,080	9,623
2018-05-02	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Exercise / conversion M	Common Stock	4,202	$17.09	$71,812	13,825
2018-03-16	Bebo Allison P	SVP, Human Resources	Open-market sell S	Common Stock	7,000	$38.75	$271,250	21,406
2018-03-14	Wendell Amy McBride	Dir	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	7,551	$0.00	$0	7,551
2018-03-14	Wendell Amy McBride	Dir	Open-market buy P	Common Stock	5,200	$38.43	$199,826	10,297
2018-03-14	Wendell Amy McBride	Dir	Equity grant / award A	Common Stock	2,406	—	—	5,097
2018-03-07	McMahon Robert W.	Chief Financial Officer	Exercise / conversion M · derivative	Restricted Stock Unit Award (Right To Receive)	732	—	—	712
2018-03-07	McMahon Robert W.	Chief Financial Officer	Exercise / conversion M	Common Stock	732	—	—	112,596
2018-02-13	Nawana Namal	Dir	Open-market buy P	Common Stock	6,600	$37.88	$250,023	6,954
2018-02-02	Bebo Allison P	SVP, Human Resources	Other disposed transaction F	Common Stock	267	$42.04	$11,225	28,406
2018-02-02	Bebo Allison P	SVP, Human Resources	Other disposed transaction F	Common Stock	4,357	$42.04	$183,168	28,673
2018-01-11	Nawana Namal	Dir	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	1,113	$0.00	$0	1,113
2018-01-11	Nawana Namal	Dir	Equity grant / award A	Common Stock	354	—	—	354
2017-12-14	McMahon Robert W.	Chief Financial Officer	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	4,565	$0.00	$0	4,565
2017-12-14	McMahon Robert W.	Chief Financial Officer	Equity grant / award A	Common Stock	1,454	—	—	111,864
2017-12-08	MACMILLAN STEPHEN P	Chairman, President and CEO	Other disposed transaction J	Common Stock	10,859	$42.69	$463,571	1,422,675
2017-12-06	MACMILLAN STEPHEN P	Chairman, President and CEO	Exercise / conversion M · derivative	Restricted Stock Unit Award (Right To Receive)	28,040	—	—	0
2017-12-06	MACMILLAN STEPHEN P	Chairman, President and CEO	Exercise / conversion M · derivative	Restricted Stock Unit Award (Right To Receive)	19,628	—	—	0
2017-12-06	MACMILLAN STEPHEN P	Chairman, President and CEO	Exercise / conversion M	Common Stock	28,040	—	—	1,433,534
2017-12-06	MACMILLAN STEPHEN P	Chairman, President and CEO	Other disposed transaction F	Common Stock	9,673	$41.44	$400,849	1,405,494
2017-12-06	MACMILLAN STEPHEN P	Chairman, President and CEO	Exercise / conversion M	Common Stock	19,628	—	—	1,415,167
2017-12-01	West Thomas A.	Div President & GM, Diagnostic	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	19,215	$0.00	$0	19,215
2017-12-01	West Thomas A.	Div President & GM, Diagnostic	Equity grant / award A	Common Stock	6,119	—	—	28,906
2017-12-01	West Thomas A.	Div President & GM, Diagnostic	Other disposed transaction F	Common Stock	1,082	$40.85	$44,200	22,787
2017-11-20	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Open-market sell S	Common Stock	1,023	$39.84	$40,756	7,546
2017-11-18	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Exercise / conversion M · derivative	Restricted Stock Unit Award (Right To Receive)	1,515	—	—	0
2017-11-18	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Other disposed transaction F	Common Stock	492	$39.96	$19,660	8,569
2017-11-18	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Exercise / conversion M	Common Stock	1,515	—	—	9,061
2017-11-14	ULLIAN ELAINE	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	3,492	$0.00	$0	0
2017-11-14	ULLIAN ELAINE	Dir	Exercise / conversion M	Common Stock	3,492	$18.82	$65,719	27,302
2017-11-13	ULLIAN ELAINE	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	9,282	$0.00	$0	3,492
2017-11-13	ULLIAN ELAINE	Dir	Open-market sell S	Common Stock	9,282	$40.50	$375,921	23,810
2017-11-13	ULLIAN ELAINE	Dir	Exercise / conversion M	Common Stock	9,282	$18.82	$174,687	33,092
2017-11-08	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Open-market sell S	Common Stock	1,256	$39.29	$49,348	7,546
2017-11-07	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Exercise / conversion M · derivative	Restricted Stock Unit Award (Right To Receive)	1,860	—	—	1,860
2017-11-07	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Other disposed transaction F	Common Stock	604	$39.50	$23,858	8,802
2017-11-07	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Exercise / conversion M	Common Stock	1,860	—	—	9,406
2017-11-05	West Thomas A.	Div President & GM, Diagnostic	Exercise / conversion M · derivative	Restricted Stock Unit Award (Right To Receive)	2,085	—	—	2,086
2017-11-05	West Thomas A.	Div President & GM, Diagnostic	Exercise / conversion M	Common Stock	2,085	—	—	23,869
2017-10-11	Levy Lawrence M	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	3,178	$0.00	$0	0
2017-10-11	Levy Lawrence M	Dir	Exercise / conversion M	Common Stock	3,178	$18.82	$59,810	32,615
2017-10-10	Levy Lawrence M	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	9,596	$0.00	$0	3,178
2017-10-10	Levy Lawrence M	Dir	Open-market sell S	Common Stock	9,596	$36.81	$353,219	29,437
2017-10-10	Levy Lawrence M	Dir	Exercise / conversion M	Common Stock	9,596	$18.82	$180,597	39,033
2017-10-09	Levy Lawrence M	Dir	Open-market sell S	Common Stock	7,138	$37.38	$266,818	29,437
2017-10-03	West Thomas A.	Div President & GM, Diagnostic	Exercise / conversion M · derivative	Restricted Stock Unit Award (Right To Receive)	4,063	—	$0	4,064
2017-10-03	West Thomas A.	Div President & GM, Diagnostic	Exercise / conversion M	Common Stock	4,063	—	—	21,784
2017-09-07	Levy Lawrence M	Dir	Open-market sell S	Common Stock	7,139	$39.04	$278,707	36,575
2017-08-04	ULLIAN ELAINE	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	998	$0.00	$0	0
2017-08-04	ULLIAN ELAINE	Dir	Exercise / conversion M	Common Stock	998	$32.81	$32,749	24,808
2017-08-03	ULLIAN ELAINE	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	6,902	$0.00	$0	998
2017-08-03	ULLIAN ELAINE	Dir	Open-market sell S	Common Stock	6,902	$40.12	$276,908	23,810
2017-08-03	ULLIAN ELAINE	Dir	Exercise / conversion M	Common Stock	6,902	$32.81	$226,489	30,712
2017-07-18	ULLIAN ELAINE	Dir	Equity grant / award G	Common Stock	1,451	$0.00	$0	23,810
2017-07-17	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Open-market sell S	Common Stock	4,704	$45.19	$212,574	7,546
2017-07-05	ULLIAN ELAINE	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	1,451	$0.00	$0	7,900
2017-07-05	ULLIAN ELAINE	Dir	Exercise / conversion M	Common Stock	1,451	$32.81	$47,615	25,261
2017-07-03	ULLIAN ELAINE	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	8,849	$0.00	$0	9,351
2017-07-03	ULLIAN ELAINE	Dir	Open-market sell S	Common Stock	8,849	$45.28	$400,674	23,810
2017-07-03	ULLIAN ELAINE	Dir	Exercise / conversion M	Common Stock	8,849	$32.81	$290,380	32,659
2017-06-26	ULLIAN ELAINE	Dir	Equity grant / award G	Common Stock	1,362	$0.00	$0	23,810
2017-06-08	Levy Lawrence M	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	1,040	$0.00	$0	0
2017-06-08	Levy Lawrence M	Dir	Exercise / conversion M	Common Stock	1,040	$32.81	$34,128	43,714
2017-06-07	Levy Lawrence M	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	2,960	$0.00	$0	1,040
2017-06-07	Levy Lawrence M	Dir	Open-market sell S	Common Stock	2,960	$44.54	$131,838	42,674
2017-06-07	Levy Lawrence M	Dir	Exercise / conversion M	Common Stock	2,960	$32.81	$97,132	45,634
2017-06-05	ULLIAN ELAINE	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	1,362	$0.00	$0	18,200
2017-06-05	ULLIAN ELAINE	Dir	Exercise / conversion M	Common Stock	1,362	$32.81	$44,694	25,172
2017-06-02	ULLIAN ELAINE	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	8,938	$0.00	$0	19,562
2017-06-02	ULLIAN ELAINE	Dir	Open-market sell S	Common Stock	8,938	$43.99	$393,183	23,810
2017-06-02	ULLIAN ELAINE	Dir	Exercise / conversion M	Common Stock	8,938	$32.81	$293,300	32,748
2017-06-01	Levy Lawrence M	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	2,854	$0.00	$0	4,000
2017-06-01	Levy Lawrence M	Dir	Exercise / conversion M	Common Stock	2,854	$32.81	$93,654	42,674
2017-05-31	Levy Lawrence M	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	9,146	$0.00	$0	6,854
2017-05-31	Levy Lawrence M	Dir	Open-market sell S	Common Stock	9,146	$43.27	$395,720	39,820
2017-05-31	Levy Lawrence M	Dir	Exercise / conversion M	Common Stock	9,146	$32.81	$300,126	48,966
2017-05-30	Valenti Peter J. III	Division Pres., Breast Health	Open-market sell S	Common Stock	2,239	$43.33	$97,016	13,228
2017-05-26	Valenti Peter J. III	Division Pres., Breast Health	Exercise / conversion M · derivative	Restricted Stock Unit Award (Right To Receive)	3,411	—	—	3,411
2017-05-26	Valenti Peter J. III	Division Pres., Breast Health	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	7,766	$0.00	$0	15,532
2017-05-26	Valenti Peter J. III	Division Pres., Breast Health	Other disposed transaction F	Common Stock	1,172	$43.35	$50,806	15,467
2017-05-26	Valenti Peter J. III	Division Pres., Breast Health	Exercise / conversion M	Common Stock	3,411	—	—	16,639
2017-05-26	Valenti Peter J. III	Division Pres., Breast Health	Open-market sell S	Common Stock	7,766	$43.47	$337,619	13,228
2017-05-26	Valenti Peter J. III	Division Pres., Breast Health	Exercise / conversion M	Common Stock	7,766	$23.82	$184,986	20,994
2017-05-25	Levy Lawrence M	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	2,807	$0.00	$0	16,000
2017-05-25	Levy Lawrence M	Dir	Exercise / conversion M	Common Stock	2,807	$32.81	$92,112	39,820
2017-05-24	Levy Lawrence M	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	9,193	$0.00	$0	18,807
2017-05-24	Levy Lawrence M	Dir	Open-market sell S	Common Stock	9,193	$42.93	$394,655	37,013
2017-05-24	Levy Lawrence M	Dir	Exercise / conversion M	Common Stock	9,193	$32.81	$301,668	46,206
2017-05-18	Levy Lawrence M	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	2,924	$0.00	$0	28,000
2017-05-18	Levy Lawrence M	Dir	Exercise / conversion M	Common Stock	2,924	$32.81	$95,951	37,013
2017-05-17	Levy Lawrence M	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	9,076	$0.00	$0	30,924
2017-05-17	Levy Lawrence M	Dir	Open-market sell S	Common Stock	9,076	$42.80	$388,470	34,089
2017-05-17	Levy Lawrence M	Dir	Exercise / conversion M	Common Stock	9,076	$32.81	$297,829	43,165
2017-05-16	ULLIAN ELAINE	Dir	Equity grant / award G	Common Stock	1,444	$0.00	$0	23,810
2017-05-15	Dockendorff Charles J	Dir	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	5,396	$0.00	$0	5,396
2017-05-15	Dockendorff Charles J	Dir	Equity grant / award A	Common Stock	1,747	$0.00	$0	2,370
2017-05-11	Levy Lawrence M	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	3,349	$0.00	$0	40,000
2017-05-11	Levy Lawrence M	Dir	Exercise / conversion M	Common Stock	3,349	$32.81	$109,897	34,089
2017-05-10	Levy Lawrence M	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	8,651	$0.00	$0	43,349
2017-05-10	Levy Lawrence M	Dir	Open-market sell S	Common Stock	1,186	$45.42	$53,868	30,740
2017-05-10	Levy Lawrence M	Dir	Open-market sell S	Common Stock	8,651	$45.33	$392,107	31,926
2017-05-10	Levy Lawrence M	Dir	Exercise / conversion M	Common Stock	8,651	$32.81	$283,883	40,577
2017-05-04	ULLIAN ELAINE	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	1,444	$0.00	$0	28,500
2017-05-04	ULLIAN ELAINE	Dir	Exercise / conversion M	Common Stock	1,444	$32.81	$47,385	25,254
2017-05-03	ULLIAN ELAINE	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	8,856	$0.00	$0	29,944
2017-05-03	ULLIAN ELAINE	Dir	Open-market sell S	Common Stock	8,856	$45.09	$399,317	23,810
2017-05-03	ULLIAN ELAINE	Dir	Exercise / conversion M	Common Stock	8,856	$32.81	$290,610	32,666
2017-05-01	CRAWFORD SALLY	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	3,231	$0.00	$0	0
2017-05-01	CRAWFORD SALLY	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	4,449	$0.00	$0	0
2017-05-01	CRAWFORD SALLY	Dir	Exercise / conversion M	Common Stock	3,231	$32.81	$106,025	151,047
2017-05-01	CRAWFORD SALLY	Dir	Exercise / conversion M	Common Stock	4,449	$18.82	$83,730	147,816
2017-04-28	CRAWFORD SALLY	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	16,769	$0.00	$0	3,231
2017-04-28	CRAWFORD SALLY	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	8,325	$0.00	$0	4,449
2017-04-28	CRAWFORD SALLY	Dir	Open-market sell S	Common Stock	16,769	$45.00	$754,605	143,367
2017-04-28	CRAWFORD SALLY	Dir	Exercise / conversion M	Common Stock	16,769	$32.81	$550,275	160,136
2017-04-28	CRAWFORD SALLY	Dir	Open-market sell S	Common Stock	8,325	$45.00	$374,625	143,367
2017-04-28	CRAWFORD SALLY	Dir	Exercise / conversion M	Common Stock	8,325	$18.82	$156,676	151,692
2017-04-27	Levy Lawrence M	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	3,126	$0.00	$0	64,000
2017-04-27	Levy Lawrence M	Dir	Exercise / conversion M	Common Stock	3,126	$32.81	$102,580	30,129
2017-04-26	Levy Lawrence M	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	8,874	$0.00	$0	67,126
2017-04-26	Levy Lawrence M	Dir	Open-market sell S	Common Stock	1,500	$44.42	$66,630	27,003
2017-04-26	Levy Lawrence M	Dir	Open-market sell S	Common Stock	8,874	$44.47	$394,604	28,503
2017-04-26	Levy Lawrence M	Dir	Exercise / conversion M	Common Stock	8,874	$32.81	$291,200	37,377
2017-04-26	ULLIAN ELAINE	Dir	Equity grant / award G	Common Stock	1,196	$0.00	$0	23,810
2017-04-20	Levy Lawrence M	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	2,664	$0.00	$0	76,000
2017-04-20	Levy Lawrence M	Dir	Exercise / conversion M	Common Stock	2,664	$32.81	$87,419	28,503
2017-04-19	Levy Lawrence M	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	9,336	$0.00	$0	78,664
2017-04-19	Levy Lawrence M	Dir	Open-market sell S	Common Stock	9,336	$42.50	$396,743	25,839
2017-04-19	Levy Lawrence M	Dir	Exercise / conversion M	Common Stock	9,336	$32.81	$306,361	35,175
2017-04-19	Levy Lawrence M	Dir	Open-market sell S	Common Stock	1,500	$42.44	$63,660	25,839
2017-04-14	Compton Eric B.	COO	Exercise / conversion M · derivative	Performance Stock Unit Award (Right to Receive)	70,367	—	$0	0
2017-04-14	Compton Eric B.	COO	Equity grant / award A · derivative	Performance Stock Unit Award (Right to Receive)	34,465	—	$0	70,367
2017-04-14	Compton Eric B.	COO	Exercise / conversion M · derivative	Restricted Stock Unit Award (Right To Receive)	4,188	—	$0	4,189
2017-04-14	Compton Eric B.	COO	Other disposed transaction F	Common Stock	29,836	$42.42	$1,265,643	71,812
2017-04-14	Compton Eric B.	COO	Exercise / conversion M	Common Stock	70,367	—	—	101,648
2017-04-14	Compton Eric B.	COO	Exercise / conversion M	Common Stock	4,188	—	—	31,281
2017-04-13	Levy Lawrence M	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	2,743	$0.00	$0	88,000
2017-04-13	Levy Lawrence M	Dir	Exercise / conversion M	Common Stock	2,743	$32.81	$90,012	27,339
2017-04-12	Levy Lawrence M	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	9,257	$0.00	$0	90,743
2017-04-12	Levy Lawrence M	Dir	Open-market sell S	Common Stock	9,257	$42.44	$392,895	24,596
2017-04-12	Levy Lawrence M	Dir	Exercise / conversion M	Common Stock	9,257	$32.81	$303,768	33,853
2017-04-12	Levy Lawrence M	Dir	Open-market sell S	Common Stock	1,500	$42.51	$63,765	24,596
2017-04-04	CRAWFORD SALLY	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	2,823	$0.00	$0	40,000
2017-04-04	CRAWFORD SALLY	Dir	Exercise / conversion M	Common Stock	2,823	$32.81	$92,637	140,336
2017-04-03	CRAWFORD SALLY	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	17,177	$0.00	$0	42,823
2017-04-03	CRAWFORD SALLY	Dir	Open-market sell S	Common Stock	17,177	$43.00	$738,611	137,513
2017-04-03	CRAWFORD SALLY	Dir	Exercise / conversion M	Common Stock	17,177	$32.81	$563,663	154,690
2017-03-09	CRAWFORD SALLY	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	2,604	$0.00	$0	60,000
2017-03-09	CRAWFORD SALLY	Dir	Exercise / conversion M	Common Stock	2,604	$32.81	$85,450	137,513
2017-03-08	CRAWFORD SALLY	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	17,396	$0.00	$0	62,604
2017-03-08	CRAWFORD SALLY	Dir	Open-market sell S	Common Stock	17,396	$42.00	$730,632	134,909
2017-03-08	CRAWFORD SALLY	Dir	Exercise / conversion M	Common Stock	17,396	$32.81	$570,850	152,305
2017-03-07	McMahon Robert W.	Chief Financial Officer	Exercise / conversion M · derivative	Restricted Stock Unit Award (Right To Receive)	711	—	—	1,444
2017-03-07	McMahon Robert W.	Chief Financial Officer	Other disposed transaction F	Common Stock	262	$40.96	$10,732	29,062
2017-03-07	McMahon Robert W.	Chief Financial Officer	Exercise / conversion M	Common Stock	711	—	—	29,324
2017-03-06	LEAMING NANCY	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	1,389	$0.00	$0	40,000
2017-03-06	LEAMING NANCY	Dir	Exercise / conversion M	Common Stock	1,389	$32.81	$45,580	53,168
2017-03-03	LEAMING NANCY	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	8,611	$0.00	$0	41,389
2017-03-03	LEAMING NANCY	Dir	Open-market sell S	Common Stock	8,611	$40.82	$351,501	51,779
2017-03-03	LEAMING NANCY	Dir	Exercise / conversion M	Common Stock	8,611	$32.81	$282,570	60,390
2017-02-10	LEAMING NANCY	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	1,246	$0.00	$0	50,000
2017-02-10	LEAMING NANCY	Dir	Exercise / conversion M	Common Stock	1,246	$32.81	$40,887	51,779
2017-02-09	LEAMING NANCY	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	8,754	$0.00	$0	51,246
2017-02-09	LEAMING NANCY	Dir	Open-market sell S	Common Stock	8,754	$40.00	$350,160	50,533
2017-02-09	LEAMING NANCY	Dir	Exercise / conversion M	Common Stock	8,754	$32.81	$287,263	59,287
2017-02-06	ULLIAN ELAINE	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	877	$0.00	$0	59,400
2017-02-06	ULLIAN ELAINE	Dir	Exercise / conversion M	Common Stock	877	$32.81	$28,779	28,252
2017-02-03	ULLIAN ELAINE	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	9,423	$0.00	$0	60,277
2017-02-03	ULLIAN ELAINE	Dir	Open-market sell S	Common Stock	9,423	$39.54	$372,585	27,375
2017-02-03	ULLIAN ELAINE	Dir	Exercise / conversion M	Common Stock	9,423	$32.81	$309,216	36,798
2017-02-02	Griffin John M.	General Counsel	Exercise / conversion M · derivative	Restricted Stock Unit Award (Right To Receive)	1,033	—	$0	2,066
2017-02-02	Griffin John M.	General Counsel	Exercise / conversion M · derivative	Restricted Stock Unit Award (Right To Receive)	1,343	—	$0	2,686
2017-02-02	Griffin John M.	General Counsel	Other disposed transaction F	Common Stock	358	$39.47	$14,130	14,125
2017-02-02	Griffin John M.	General Counsel	Exercise / conversion M	Common Stock	1,033	—	—	14,483
2017-02-02	Griffin John M.	General Counsel	Other disposed transaction F	Common Stock	507	$39.47	$20,011	13,450
2017-02-02	Griffin John M.	General Counsel	Exercise / conversion M	Common Stock	1,343	—	—	13,957
2017-01-04	ULLIAN ELAINE	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	949	$0.00	$0	69,700
2017-01-04	ULLIAN ELAINE	Dir	Exercise / conversion M	Common Stock	949	$32.81	$31,141	27,375
2017-01-03	ULLIAN ELAINE	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	9,351	$0.00	$0	70,649
2017-01-03	ULLIAN ELAINE	Dir	Open-market sell S	Common Stock	9,351	$40.00	$374,040	26,426
2017-01-03	ULLIAN ELAINE	Dir	Exercise / conversion M	Common Stock	9,351	$32.81	$306,853	35,777
2016-12-14	Wendell Amy McBride	Dir	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	1,500	$0.00	$0	1,500
2016-12-14	Wendell Amy McBride	Dir	Equity grant / award A	Common Stock	485	—	—	485
2016-12-13	MACMILLAN STEPHEN P	Chairman, President and CEO	Other disposed transaction J	Common Stock	7,395	$40.52	$299,645	788,812
2016-12-06	MACMILLAN STEPHEN P	Chairman, President and CEO	Exercise / conversion M · derivative	Performance Stock Unit Award (Right to Receive)	307,760	—	$0	0
2016-12-06	MACMILLAN STEPHEN P	Chairman, President and CEO	Equity grant / award A · derivative	Performance Stock Unit Award (Right to Receive)	150,739	—	$0	307,760
2016-12-06	MACMILLAN STEPHEN P	Chairman, President and CEO	Exercise / conversion M · derivative	Restricted Stock Unit Award (Right To Receive)	28,039	—	—	28,040
2016-12-06	MACMILLAN STEPHEN P	Chairman, President and CEO	Exercise / conversion M · derivative	Restricted Stock Unit Award (Right To Receive)	19,628	—	—	19,628
2016-12-06	MACMILLAN STEPHEN P	Chairman, President and CEO	Exercise / conversion M	Common Stock	307,760	—	—	796,207
2016-12-06	MACMILLAN STEPHEN P	Chairman, President and CEO	Exercise / conversion M	Common Stock	28,039	—	—	488,447
2016-12-06	MACMILLAN STEPHEN P	Chairman, President and CEO	Other disposed transaction F	Common Stock	9,530	$38.89	$370,622	460,408
2016-12-06	MACMILLAN STEPHEN P	Chairman, President and CEO	Exercise / conversion M	Common Stock	19,628	—	—	469,938
2016-12-01	Compton Eric B.	COO	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	35,919	$0.00	$0	35,919
2016-12-01	Compton Eric B.	COO	Equity grant / award A	Common Stock	11,623	—	—	26,317
2016-12-01	MACMILLAN STEPHEN P	Chairman, President and CEO	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	160,565	$0.00	$0	160,565
2016-12-01	MACMILLAN STEPHEN P	Chairman, President and CEO	Equity grant / award A	Common Stock	9,623	—	—	450,310
2016-12-01	MACMILLAN STEPHEN P	Chairman, President and CEO	Equity grant / award A	Common Stock	51,957	—	—	440,687
2016-12-01	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	7,389	$0.00	$0	7,389
2016-12-01	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Equity grant / award A	Common Stock	2,391	—	—	11,456
2016-11-21	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Open-market sell S	Common Stock	3,023	$38.32	$115,841	9,065
2016-11-18	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Exercise / conversion M · derivative	Restricted Stock Unit Award (Right To Receive)	1,515	—	—	1,515
2016-11-18	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Exercise / conversion M · derivative	Restricted Stock Unit Award (Right To Receive)	4,195	—	—	0
2016-11-18	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Other disposed transaction F	Common Stock	713	$38.37	$27,358	12,088
2016-11-18	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Exercise / conversion M	Common Stock	1,515	—	—	12,801
2016-11-18	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Other disposed transaction F	Common Stock	1,974	$38.37	$75,742	11,286
2016-11-18	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Exercise / conversion M	Common Stock	4,195	—	—	13,260
2016-11-15	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Open-market sell S	Common Stock	1,211	$36.55	$44,262	9,065
2016-11-14	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Exercise / conversion M · derivative	Restricted Stock Unit Award (Right To Receive)	1,794	—	—	0
2016-11-14	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Other disposed transaction F	Common Stock	583	$36.45	$21,250	10,276
2016-11-14	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Exercise / conversion M	Common Stock	1,794	—	—	10,859
2016-11-08	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Open-market sell S	Common Stock	984	$38.57	$37,953	9,065
2016-11-07	Compton Eric B.	COO	Exercise / conversion M · derivative	Restricted Stock Unit Award (Right To Receive)	3,636	—	$0	7,273
2016-11-07	Compton Eric B.	COO	Exercise / conversion M	Common Stock	3,636	—	—	14,694
2016-11-05	MACMILLAN STEPHEN P	Chairman, President and CEO	Exercise / conversion M · derivative	Restricted Stock Unit Award (Right To Receive)	15,119	—	—	30,238
2016-11-05	MACMILLAN STEPHEN P	Chairman, President and CEO	Exercise / conversion M	Common Stock	15,119	—	—	377,347
2016-11-04	Compton Eric B.	COO	Exercise / conversion M · derivative	Restricted Stock Unit Award (Right To Receive)	3,128	—	$0	6,256
2016-11-04	Compton Eric B.	COO	Other disposed transaction F	Common Stock	1,016	$38.08	$38,689	11,058
2016-11-04	Compton Eric B.	COO	Exercise / conversion M	Common Stock	3,128	—	—	12,074
2016-10-10	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	6,916	$0.00	$0	10,375
2016-10-10	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	7,994	$0.00	$0	7,994
2016-10-10	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	8,402	$0.00	$0	4,202
2016-10-10	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	8,158	$0.00	$0	0
2016-10-10	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Open-market sell S	Common Stock	31,470	$40.00	$1,258,800	9,065
2016-10-10	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Exercise / conversion M	Common Stock	6,916	$21.45	$148,348	40,317
2016-10-10	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Exercise / conversion M	Common Stock	7,994	$19.86	$158,761	33,401
2016-10-10	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Exercise / conversion M	Common Stock	8,402	$17.09	$143,590	25,407
2016-10-10	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Exercise / conversion M	Common Stock	8,158	$16.82	$137,218	17,005
2016-10-03	West Thomas A.	Div President & GM, Diagnostic	Exercise / conversion M · derivative	Restricted Stock Unit Award (Right To Receive)	4,063	—	$0	8,127
2016-10-03	West Thomas A.	Div President & GM, Diagnostic	Other disposed transaction F	Common Stock	1,564	$38.80	$60,683	6,340
2016-10-03	West Thomas A.	Div President & GM, Diagnostic	Exercise / conversion M	Common Stock	4,063	—	—	7,099
2016-07-21	CRAWFORD SALLY	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	16,071	$0.00	$0	0
2016-07-21	CRAWFORD SALLY	Dir	Open-market sell S	Common Stock	16,071	$37.00	$594,627	127,902
2016-07-21	CRAWFORD SALLY	Dir	Exercise / conversion M	Common Stock	16,071	$14.50	$233,030	143,973
2016-07-12	LEAMING NANCY	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	5,029	$0.00	$0	0
2016-07-12	LEAMING NANCY	Dir	Exercise / conversion M	Common Stock	5,029	$14.50	$72,920	58,961
2016-07-11	LEAMING NANCY	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	5,100	$0.00	$0	5,029
2016-07-11	LEAMING NANCY	Dir	Open-market sell S	Common Stock	5,100	$36.05	$183,855	53,932
2016-07-11	LEAMING NANCY	Dir	Exercise / conversion M	Common Stock	5,100	$14.50	$73,950	59,032
2016-07-08	LEAMING NANCY	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	1,121	$0.00	$0	10,129
2016-07-08	LEAMING NANCY	Dir	Open-market sell S	Common Stock	1,121	$36.00	$40,356	53,932
2016-07-08	LEAMING NANCY	Dir	Exercise / conversion M	Common Stock	1,121	$14.50	$16,254	55,053
2016-06-17	ULLIAN ELAINE	Dir	Exercise / conversion M · derivative	Restricted Stock Unit Award (Right To Receive)	401	—	$0	0
2016-06-17	ULLIAN ELAINE	Dir	Exercise / conversion M	Common Stock	401	—	—	24,662
2016-06-01	Levy Lawrence M	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	16,000	$0.00	$0	0
2016-06-01	Levy Lawrence M	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	16,071	$0.00	$0	0
2016-06-01	Levy Lawrence M	Dir	Open-market sell S	Common Stock	17,794	$34.41	$612,327	21,463
2016-06-01	Levy Lawrence M	Dir	Exercise / conversion M	Common Stock	16,000	$23.64	$378,240	39,257
2016-06-01	Levy Lawrence M	Dir	Exercise / conversion M	Common Stock	16,071	$14.50	$233,030	23,257
2016-05-26	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	4,228	$0.00	$0	0
2016-05-26	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Exercise / conversion M · derivative	Restricted Stock Unit Award (Right To Receive)	525	—	$0	1,050
2016-05-26	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Open-market sell S	Common Stock	4,228	$33.85	$143,130	8,847
2016-05-26	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Exercise / conversion M	Common Stock	4,228	$15.75	$66,591	12,881
2016-05-26	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Other disposed transaction F	Common Stock	166	$33.85	$5,619	8,653
2016-05-26	Oberton Karleen Marie	Corp. VP & Chief Acctg Officer	Exercise / conversion M	Common Stock	525	—	—	8,819

Regulatory Activity

Last 12 months to 2025-04-29

Insider Filings (Forms 3/4/5) — 12 months

Material Event Filings (8-K) — 12 months

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count